These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 34745145)

  • 21. Recovery of Memory B-cell Subsets and Persistence of Antibodies in Convalescent COVID-19 Patients.
    Rajamanickam A; Kumar NP; Nancy P A; Selvaraj N; Munisankar S; Renji RM; V V; Murhekar M; Thangaraj JWV; Kumar MS; Kumar CPG; Bhatnagar T; Ponnaiah M; Sabarinathan R; Kumar VS; Babu S
    Am J Trop Med Hyg; 2021 Sep; 105(5):1255-1260. PubMed ID: 34583334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heightened Circulating Interferon-Inducible Chemokines, and Activated Pro-Cytolytic Th1-Cell Phenotype Features Covid-19 Aggravation in the Second Week of Illness.
    Tincati C; Cannizzo ES; Giacomelli M; Badolato R; d'Arminio Monforte A; Marchetti G
    Front Immunol; 2020; 11():580987. PubMed ID: 33193384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.
    Yang G; Cao J; Qin J; Mei X; Deng S; Xia Y; Zhao J; Wang J; Luan T; Chen D; Huang P; Chen C; Sun X; Luo Q; Su J; Zhang Y; Zhong N; Wang Z
    Signal Transduct Target Ther; 2024 May; 9(1):141. PubMed ID: 38811527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A poor and delayed anti-SARS-CoV2 IgG response is associated to severe COVID-19 in children.
    Sananez I; Raiden SC; Algieri SC; Uranga M; Grisolía NA; Filippo D; De Carli N; Lalla SD; Cairoli H; Chiolo MJ; Meregalli CN; Cohen E; Mosquera G; Marcó Del Pont M; Giménez LI; Gregorio G; Sarli M; Alcalde AL; Davenport C; Bruera MJ; Simaz N; Pérez MF; Nivela V; Bayle C; Alvarez L; Revetria M; Tuccillo P; Agosta MT; Pérez H; Nova SV; Suárez P; Takata EM; García M; Lattner J; Rolón MJ; Coll P; Salvatori M; Piccardo C; Russo C; Varese A; Seery V; Holgado MP; Polo ML; Ceballos A; Nuñez M; Penedo JMG; Ferrero F; Geffner J; Arruvito L
    EBioMedicine; 2021 Oct; 72():103615. PubMed ID: 34649078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure.
    Neeland MR; Bannister S; Clifford V; Nguyen J; Dohle K; Overmars I; Toh ZQ; Anderson J; Donato CM; Sarkar S; Do LAH; McCafferty C; Licciardi PV; Ignjatovic V; Monagle P; Bines JE; Mulholland K; Curtis N; McNab S; Steer AC; Burgner DP; Saffery R; Tosif S; Crawford NW
    Front Immunol; 2021; 12():741639. PubMed ID: 34721408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
    Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
    Front Immunol; 2021; 12():636768. PubMed ID: 33777028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals.
    Gil-Manso S; Miguens Blanco I; López-Esteban R; Carbonell D; López-Fernández LA; West L; Correa-Rocha R; Pion M
    Front Immunol; 2021; 12():793142. PubMed ID: 35069575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
    Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
    Front Immunol; 2021; 12():723585. PubMed ID: 34489974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
    Al-Mughales JA; Al-Mughales TJ; Saadah OI
    Front Immunol; 2021; 12():705441. PubMed ID: 34539635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
    Jiang XL; Wang GL; Zhao XN; Yan FH; Yao L; Kou ZQ; Ji SX; Zhang XL; Li CB; Duan LJ; Li Y; Zhang YW; Duan Q; Wang TC; Li ET; Wei X; Wang QY; Wang XF; Sun WY; Gao YW; Kang DM; Zhang JY; Ma MJ
    Nat Commun; 2021 Feb; 12(1):897. PubMed ID: 33563974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children.
    Neeland MR; Bannister S; Clifford V; Dohle K; Mulholland K; Sutton P; Curtis N; Steer AC; Burgner DP; Crawford NW; Tosif S; Saffery R
    Nat Commun; 2021 Feb; 12(1):1084. PubMed ID: 33597531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
    Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
    Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent COVID-19 Patients Without Comorbidities Display Similar Immunophenotypes Over Time Despite Divergent Disease Severities.
    Chu CF; Sabath F; Fibi-Smetana S; Sun S; Öllinger R; Noeßner E; Chao YY; Rinke L; Winheim E; Rad R; Krug AB; Taher L; Zielinski CE
    Front Immunol; 2021; 12():601080. PubMed ID: 34867933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute phase of COVID-19 is associated with elevated plasmablasts in the blood.
    Beran O; Matuskova K; Bartovska Z; Bartos O; Holub M
    Bratisl Lek Listy; 2022; 123(4):244-247. PubMed ID: 35294209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
    Noviello M; De Lorenzo R; Chimienti R; Maugeri N; De Lalla C; Siracusano G; Lorè NI; Rancoita PMV; Cugnata F; Tassi E; Dispinseri S; Abbati D; Beretta V; Ruggiero E; Manfredi F; Merolla A; Cantarelli E; Tresoldi C; Pastori C; Caccia R; Sironi F; Marzinotto I; Saliu F; Ghezzi S; Lampasona V; Vicenzi E; Cinque P; Manfredi AA; Scarlatti G; Dellabona P; Lopalco L; Di Serio C; Malnati M; Ciceri F; Rovere-Querini P; Bonini C
    Front Immunol; 2024; 15():1381091. PubMed ID: 39136010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.